IXICO (LON:IXI) Shares Pass Below Two Hundred Day Moving Average – Should You Sell?
by Renee Jackson · The Cerbat GemShares of IXICO plc (LON:IXI – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 10.51 ($0.14) and traded as low as GBX 9.50 ($0.12). IXICO shares last traded at GBX 9.75 ($0.13), with a volume of 3 shares trading hands.
IXICO Stock Performance
The company has a quick ratio of 4.90, a current ratio of 2.85 and a debt-to-equity ratio of 3.32. The stock has a 50 day simple moving average of GBX 11.26 and a two-hundred day simple moving average of GBX 10.52. The stock has a market capitalization of £9.04 million, a P/E ratio of -2.53, a P/E/G ratio of -0.38 and a beta of 0.86.
About IXICO
IXICO is a fast growing and profitable medical data analytics company, providing data management and advanced analytics to the pharmaceutical clinical trials market. Established in 2004 and listed as a public company in October 2013, IXICO has firmly established itself as a trusted partner to the global pharmaceutical industry developing new therapies for neurological conditions such as Alzheimer’s, Parkinson’s and Huntington’s disease.
Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.
Featured Articles
- Five stocks we like better than IXICO
- What is a Secondary Public Offering? What Investors Need to Know
- How to Build the Ultimate Everything ETF Portfolio
- How to Find Undervalued Stocks
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Stocks With High ROE and Market-Beating Growth Potential